ロード中...

Buprenorphine Treatment for Opioid Use Disorder: An Overview

Opioid use disorder affects over 26 million individuals worldwide. There are currently three World Health Organization recommended and Food and Drug Administration (FDA) approved medication treatments for opioid use disorder: the full opioid agonist methadone, the opioid partial-agonist buprenorphin...

詳細記述

保存先:
書誌詳細
出版年:CNS Drugs
主要な著者: Shulman, Matisyahu, Wai, Jonathan M., Nunes, Edward V.
フォーマット: Artigo
言語:Inglês
出版事項: 2019
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6585403/
https://ncbi.nlm.nih.gov/pubmed/31062259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-019-00637-z
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!